4SC 208Alternative Names: 4SC-208
Latest Information Update: 07 Feb 2017
At a glance
- Originator 4SC
- Class Antineoplastics; Small molecules
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 01 Jan 2017 Preclinical trials in Cancer in Germany (unspecified route)